ANAESTHESIOLOGY - GENERAL ANAESTHESIA / LETTER TO EDITOR
GLP-1 agonists: a new hope for patients, a new challenge for anaesthetists
1
2nd Department of Anaesthesiology and Intensive Care, Medical University of Warsaw, Poland
2
Department of Anaesthesia and Intensive Care, A.O.U. Policlinico-San Marco, Site “Policlinico G. Rodolico”, Catania, Italy
3
Section of Anaesthesia, Department of General Surgery and Medical-Surgical Specialties, University of Catania, 95124 Catania, Italy
Submission date: 2025-01-18
Acceptance date: 2025-03-20
Publication date: 2025-05-15
Corresponding author
Mateusz Zawadka
2nd Department of Anaesthesiology and Intensive Care, Medical University of Warsaw, 1a Banacha St., 02-097 Warsaw, Poland
2nd Department of Anaesthesiology and Intensive Care, Medical University of Warsaw, 1a Banacha St., 02-097 Warsaw, Poland
Anaesthesiol Intensive Ther 2025;57(1):87-89
TOPICS
REFERENCES (24)
1.
Smith NK, Hackett TA, Galli A, Flynn CR. GLP-1: molecular mechanisms and outcomes of a complex signaling system. Neurochem Int 2019; 128: 94-105. DOI: 10.1016/j.neuint.2019.04.010.
2.
Sfairopoulos D, Liatis S, Tigas S, Liberopoulos E. Clinical pharmacology of glucagon-like peptide-1 receptor agonists. Hormones (Athens) 2018; 17: 333-350. DOI: 10.1007/s42000-018-0038-0.
3.
Mizubuti GB, Ho AM, Silva LMD, Phelan R. Perioperative management of patients on glucagon-like peptide-1 receptor agonists. Curr Opin Anaesthesiol 2024; 37: 323-333. DOI: 10.1097/ACO.0000000000001348.
4.
Nauck MA, Quast DR, Wefers J, Meier JJ. GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Mol Metab 2021; 46: 101102. DOI: 10.1016/j.molmet.2020.101102.
5.
Maselli DB, Camilleri M. Effects of GLP-1 and its analogs on gastric physiology in diabetes mellitus and obesity. Adv Exp Med Biol 2021; 1307: 171-192. DOI: 10.1007/5584_2020_496.
6.
Silveira SQ, da Silva LM, de Campos Vieira Abib A, de Moura DTH, de Moura EGH, Santos LB, et al. Relationship between perioperative semaglutide use and residual gastric content: a retrospective analysis of patients undergoing elective upper endoscopy. J Clin Anesth 2023; 87: 111091. DOI: 10.1016/j.jclinane.2023.111091.
7.
Wu F, Smith MR, Mueller AL, Klapman SA, Everett LL, Houle T, et al. Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study. Can J Anaesth 2024; 71: 958-966. DOI: 10.1007/s12630-024-02719-z.
8.
Baig MU, Piazza A, Lahooti A, Johnson KE, Rangwani S, Gouda Z, et al. Glucagon-like peptide-1 receptor agonist use and the risk of residual gastric content and aspiration in patients undergoing gastrointestinal endoscopy: a systematic review and a meta-analysis. Gastrointest Endosc 2024; 16: S0016-5107(24)03794-5. DOI: 10.1016/j.gie.2024.12.019.
9.
Nersessian RSF, da Silva LM, Carvalho MAS, Silveira SQ, Abib ACV, Bellicieri FN, et al. Relationship between residual gastric content and peri-operative semaglutide use assessed by gastric ultrasound: a prospective observational study. Anaesthesia 2024; 79: 1317-1324. DOI: 10.1111/anae.16454.
10.
Sherwin M, Hamburger J, Katz D, DeMaria S Jr. Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide. Can J Anaesth 2023; 70: 1300-1306. DOI: 10.1007/s12630-023-02549-5.
11.
Sen S, Potnuru PP, Hernandez N, Goehl C, Praestholm C, Sridhar S, Nwokolo OO. Glucagon-like peptide-1 receptor agonist use and residual gastric content before anesthesia. JAMA Surg 2024; 159: 660-667. DOI: 10.1001/jamasurg.2024.0111.
12.
Kittner SL, Talbott AL, Vishneski SR, Narbaiza J, Shields JS. Retained gastric contents after adequate fasting associated with GLP-1 receptor agonist use: a report of 3 cases. JBJS Case Connect 2023; 13. DOI: 10.2106/JBJS.CC.23.00506.
13.
Girón-Arango L, Perlas A. Point-of-care gastric ultrasound to identify a full stomach on a diabetic patient taking a glucagon-like peptide 1 receptor agonist. A A Pract 2024; 18: e01751. DOI: 10.1213/XAA.0000000000001751.
14.
Fujino E, Cobb KW, Schoenherr J, Gouker L, Lund E. Anesthesia considerations for a patient on semaglutide and delayed gastric emptying. Cureus 2023; 15: e42153. DOI: 10.7759/cureus.42153.
15.
Gulak MA, Murphy P. Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report. Can J Anaesth 2023; 70: 1397-1400. DOI: 10.1007/s12630-023-02521-3.
16.
Klein SR, Hobai IA. Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report. Can J Anaesth 2023; 70: 1394-1396. DOI: 10.1007/s12630-023-02440-3.
17.
Weber M, Siddarthan I, Mack PF. Clinically significant emesis in a patient taking a long-acting GLP-1 receptor agonist for weight loss. Br J Anaesth 2023; 131: e37-e39. DOI: 10.1016/j.bja.2023.05.005.
18.
Institute for Safe Medication Practices Canada. Glucagon-like peptide-1 (GLP-1) receptor agonists: risk of aspiration during anesthesia. 2023. Available at: https://ismpcanada.ca/bulletin....
19.
Joshi GP, LaMasters T, Kindel TL. Preprocedure care of patients on glucagon-like peptide-1 receptor agonists: a multisociety clinical practice guidance. Anesthesiology 2024; 141: 1208-1209. DOI: 10.1097/ALN.0000000000005231.
20.
Kindel TL, Wang AY, Wadhwa A, Schulman AR, Sharaiha RZ, Kroh M, et al.; American Gastroenterological Association; American Society for Metabolic and Bariatric Surgery; American Society of Anesthesiologists; International Society of Perioperative Care of Patients with Obesity; Society of American Gastrointestinal and Endoscopic Surgeons. Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Clin Gastroenterol Hepatol 2024; 29: S1542-3565(24)00910-8. DOI: 10.1016/j.cgh.2024.10.003.
21.
Joshi GP, Abdelmalak BB, Weigel WA, Soriano SG, Harbell MW, Kuo CI, et al. American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists, 2023. Available at: https://www.asahq.org/about-as....
22.
de Vries FE, Gans SL, Solomkin JS, Allegranzi B, Egger M, Dellinger EP, Boermeester MA. Meta-analysis of lower perioperative blood glucose target levels for reduction of surgical-site infection. Br J Surg 2017; 104: e95-e105. DOI: 10.1002/bjs.10424.
23.
El-Boghdadly K, Dhesi J, Fabb P, Levy N, Lobo DN, McKechnie A, et al. Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: a consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association. Anaesthesia 2025; 80: 412-424. DOI: 10.1111/anae.16541.
24.
Hulst AH, Hermanides J, van Zuylen ML. Residual gastric content and peri-operative semaglutide use assessed by gastric ultrasound. Anaesthesia 2025; 80: 338-339. DOI: 10.1111/anae.16504.
| eISSN: | 1731-2531 |
| ISSN: | 1642-5758 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
